Impact of bladder catheterization during elective cesarean delivery
A Randomized Controlled Trial of Use Versus Non-use of Bladder Catheterization in Elective Cesarean Delivery
This study is testing whether using a bladder catheter during scheduled cesarean deliveries helps women recover faster and have fewer complications compared to not using one.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 140 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Calgary Academic / other |
| Locations | 1 site (Calgary, Alberta) |
| Trial ID | NCT06242756 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial aims to evaluate the effects of routine bladder catheterization on various outcomes in women undergoing uncomplicated cesarean sections. Conducted at the Foothills Medical Centre in Calgary, Alberta, participants will be randomly assigned to either a catheterized or non-catheterized group before their scheduled delivery. The study will assess factors such as hospitalization time, time to ambulation, urinary retention, urinary tract infections, bladder injury prevention, operating time, and patient satisfaction. Randomization will be stratified by parity to ensure balanced treatment groups.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older with a singleton pregnancy scheduled for an elective primary or repeat cesarean section.
Not a fit: Patients with abnormal placentation, such as placenta previa or suspected invasive disease, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved recovery times and reduced complications for patients undergoing cesarean deliveries.
How similar studies have performed: While the approach of evaluating catheterization in cesarean deliveries is not widely tested, similar studies have shown varying outcomes regarding catheter use in surgical settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: - women who are 18 years of age or older with a singleton pregnancy presenting for an elective primary or repeat CS. Exclusion criteria: - diagnosis of abnormal placentation including placenta previa, vasa previa, or suspected invasive disease
Where this trial is running
Calgary, Alberta
- University of Calgary — Calgary, Alberta, Canada (Recruiting)
Study contacts
- Principal investigator: Stephen L. Wood, MD, MSc — University of Calgary
- Study coordinator: Stephen L. Wood, MD, MSc
- Email: stephen.wood@albertahealthservices.ca
- Phone: 403-944-1438
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.